XML 20 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jan. 31, 2018
Jul. 31, 2017
Current assets:    
Cash and cash equivalents $ 106,433 $ 110,670
Trading securities 0 11,898
Accounts receivable, trade, net of allowance for doubtful accounts of $75 and $616 at January 31, 2018 and July 31, 2017, respectively 110,834 81,450
Inventories, net 45,211 34,369
Funds held for clients 13,074 13,454
Prepaid expenses and other current assets 17,204 6,005
Total current assets 292,756 257,846
Property and equipment, net 105,411 18,555
Goodwill 259,085  
Other intangible assets, net 206,819  
Other assets 6,039 4,897
Total assets 870,110 281,298
Current liabilities:    
Accounts payable 85,010 71,476
Accrued restructuring 112 186
Accrued expenses 74,671 37,898
Funds held for clients 13,074 13,454
Current portion of long-term debt 5,725  
Other current liabilities 43,561 26,141
Total current liabilities 222,153 149,155
Notes payable 62,062 59,758
Long-term debt, excluding current portion 385,975  
Other long-term liabilities 30,693 9,414
Long-term liabilities 478,730 69,172
Total liabilities 700,883 218,327
Contingently redeemable preferred stock, $0.01 par value per share. 35,000 shares authorized, issued and outstanding shares at January 31, 2018; zero shares authorized, issued and outstanding shares at July 31, 2017 (Note 11) 35,259  
Stockholders' equity:    
Preferred stock, $0.01 par value per share. Authorized 4,965,000 and 5,000,000 shares at January 31, 2018 and July 31, 2017, respectively; zero issued and outstanding shares at January 31, 2018 and at July 31, 2017
Common stock, $0.01 par value per share. Authorized 1,400,000,000 shares; 60,205,946 issued and outstanding shares at January 31, 2018; 55,555,973 issued and outstanding shares at July 31, 2017 603 556
Additional paid-in capital 7,464,451 7,457,051
Accumulated deficit (7,339,367) (7,398,949)
Accumulated other comprehensive income 8,281 4,313
Total stockholders' equity 133,968 62,971
Total liabilities, contingently redeemable preferred stock and stockholders' equity $ 870,110 $ 281,298